A new application about N1,N2-Di-tert-butylethane-1,2-diamine

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 4062-60-6, help many people in the next few years.category: catalyst-ligand

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent， Safety of N1,N2-Di-tert-butylethane-1,2-diamine, Which mentioned a new discovery about 4062-60-6

This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with central nervous system (CNS) disorders. In particular, it relates to the use of a alpha5- containing GABAA receptor agonist (e.g., a alpha5-containing GABAA receptor positive allosteric modulator) as described herein in treating cognitive impairment associated with central nervous system (CNS) disorders in a subject in need or at risk thereof, including, without limitation, subjects having or at risk for age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI (aMCI), Age- Associated Memory Impairment (AAMI), Age Related Cognitive Decline (ARCD), dementia, Alzheimer’ s Disease(AD), prodromal AD, post traumatic stress disorder (PTSD), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (ALS), cancer-therapy-related cognitive impairment, mental retardation, Parkinson’ s disease (PD), autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 4062-60-6, help many people in the next few years.category: catalyst-ligand

Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI